Niina Kleiber

453 total citations
37 papers, 290 citations indexed

About

Niina Kleiber is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Anesthesiology and Pain Medicine. According to data from OpenAlex, Niina Kleiber has authored 37 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 12 papers in Surgery and 7 papers in Anesthesiology and Pain Medicine. Recurrent topics in Niina Kleiber's work include Vascular Malformations and Hemangiomas (8 papers), Anesthesia and Sedative Agents (7 papers) and Pharmaceutical studies and practices (7 papers). Niina Kleiber is often cited by papers focused on Vascular Malformations and Hemangiomas (8 papers), Anesthesia and Sedative Agents (7 papers) and Pharmaceutical studies and practices (7 papers). Niina Kleiber collaborates with scholars based in Canada, Netherlands and France. Niina Kleiber's co-authors include Saskia N. de Wildt, Dick Tibboel, Josée Dubois, Erwin Ista, Yves Théorêt, Nienke J. Vet, Matthijs de Hoog, Julie Powell, Catherine McCuaïg and Thiérry Ducruet and has published in prestigious journals such as Critical Care Medicine, British Journal of Haematology and Archives of Disease in Childhood.

In The Last Decade

Niina Kleiber

34 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niina Kleiber Canada 12 89 85 74 73 38 37 290
Dominic Sanfilippo United States 10 82 0.9× 42 0.5× 68 0.9× 49 0.7× 25 0.7× 21 334
Mostafa Sadeghi Iran 12 108 1.2× 20 0.2× 75 1.0× 44 0.6× 16 0.4× 33 280
S. Roger Canada 6 397 4.5× 65 0.8× 173 2.3× 238 3.3× 32 0.8× 13 697
C. Orlikowski Australia 10 170 1.9× 49 0.6× 84 1.1× 79 1.1× 3 0.1× 14 333
Chris D. Glover United States 12 230 2.6× 72 0.8× 57 0.8× 169 2.3× 55 1.4× 19 412
Mahzad Alimian Iran 11 261 2.9× 25 0.3× 17 0.2× 190 2.6× 14 0.4× 37 358
N. Nathan France 10 156 1.8× 11 0.1× 77 1.0× 91 1.2× 19 0.5× 25 339
Aikaterini Tzortzopoulou United States 6 260 2.9× 48 0.6× 54 0.7× 135 1.8× 4 0.1× 8 429
Ivan Florentino‐Pineda United States 10 227 2.6× 38 0.4× 127 1.7× 21 0.3× 10 0.3× 14 452
Malik Benlabed France 10 105 1.2× 76 0.9× 21 0.3× 55 0.8× 20 0.5× 17 319

Countries citing papers authored by Niina Kleiber

Since Specialization
Citations

This map shows the geographic impact of Niina Kleiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niina Kleiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niina Kleiber more than expected).

Fields of papers citing papers by Niina Kleiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niina Kleiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niina Kleiber. The network helps show where Niina Kleiber may publish in the future.

Co-authorship network of co-authors of Niina Kleiber

This figure shows the co-authorship network connecting the top 25 collaborators of Niina Kleiber. A scholar is included among the top collaborators of Niina Kleiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niina Kleiber. Niina Kleiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Bournissen, Facundo, et al.. (2025). Fixed dosing of alpelisib for children with vascular anomalies: Can we do better?. British Journal of Clinical Pharmacology. 91(3). 914–920. 3 indexed citations
2.
Kleiber, Niina, et al.. (2024). Atypical Presentation and Evolution of Necrotizing Enterocolitis as a PIK3CA Pathological Variant. Cureus. 16(4). e59243–e59243. 1 indexed citations
3.
Nguyen, Christina, Evelyne D Trottier, Nelson Piché, et al.. (2023). The Three W's of Acetaminophen In Children: Who, Why, and Which Administration Mode?. The Journal of Pediatric Pharmacology and Therapeutics. 28(1). 20–28. 3 indexed citations
4.
Blincoe, Annaliesse, Pierre Teira, Henrique Bittencourt, et al.. (2023). Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis. Frontiers in Medicine. 10. 1275927–1275927.
5.
6.
Théorêt, Yves, Josée Dubois, Sandrine Essouri, et al.. (2021). Systemic, local, and sclerotherapy drugs: What do we know about drug prescribing in vascular anomalies?. Pediatric Blood & Cancer. 68(12). e29364–e29364. 4 indexed citations
7.
Kleiber, Niina, Jérôme Coulombe, Sandrine Essouri, et al.. (2021). Off-Label Use and Safety of Drug Use in Vascular Anomalies. Dermatology. 237(4). 649–657. 9 indexed citations
8.
Trottier, Evelyne D, et al.. (2021). Morphine or hydromorphone: which should be preferred? A systematic review. Archives of Disease in Childhood. 106(10). 1002–1009. 9 indexed citations
9.
10.
Pastore, Yves, Nancy Robitaille, Sylvie LeMay, et al.. (2020). Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial. British Journal of Haematology. 192(2). 385–394. 12 indexed citations
11.
Ospina, Luis H., et al.. (2019). Visual disorders with psychostimulants: A paediatric case report. Paediatrics & Child Health. 24(3). 153–155. 11 indexed citations
12.
Kleiber, Niina, Elisa A. M. Calvier, Miriam G. Mooij, et al.. (2019). Enteral Acetaminophen Bioavailability in Pediatric Intensive Care Patients Determined With an Oral Microtracer and Pharmacokinetic Modeling to Optimize Dosing. Critical Care Medicine. 47(12). e975–e983. 14 indexed citations
13.
Kleiber, Niina, et al.. (2017). CLONIDINE INDUCED BRADYCARDIA AND HYPOTENSION ARE FREQUENT IN CRITICALLY ILL CHILDREN, BUT DO NOT APPEAR TO COMPROMISE HEMODYNAMICS. Paediatrics & Child Health. 22(suppl_1). e30–e30. 1 indexed citations
14.
Kleiber, Niina, Saskia N. de Wildt, Gérard Cortina, et al.. (2016). A Comparative Analysis of Preemptive Versus Targeted Sedation on Cardiovascular Stability After High-Risk Cardiac Surgery in Infants*. Pediatric Critical Care Medicine. 17(4). 321–331. 5 indexed citations
15.
Vet, Nienke J., Niina Kleiber, Erwin Ista, Matthijs de Hoog, & Saskia N. de Wildt. (2016). Sedation in Critically Ill Children with Respiratory Failure. Frontiers in Pediatrics. 4. 89–89. 35 indexed citations
16.
Kleiber, Niina, Saskia N. de Wildt, Gérard Cortina, et al.. (2016). Clonidine as a First-Line Sedative Agent After Neonatal Cardiac Surgery. Pediatric Critical Care Medicine. 17(4). 332–341. 18 indexed citations
17.
Kleiber, Niina, France Gauvin, Marisa Tucci, et al.. (2015). Respiratory Dysfunction Associated With RBC Transfusion in Critically Ill Children. Pediatric Critical Care Medicine. 16(4). 325–334. 20 indexed citations
18.
Kleiber, Niina, et al.. (2014). ABSTRACT 535. Pediatric Critical Care Medicine. 15. 122–122. 1 indexed citations
19.
Kleiber, Niina, Krista Tromp, Miriam G. Mooij, et al.. (2014). Ethics of Drug Research in the Pediatric Intensive Care Unit. Pediatric Drugs. 17(1). 43–53. 17 indexed citations
20.
Kleiber, Niina, Philippe Chessex, Thérèse Rouleau, et al.. (2010). Neonatal Exposure to Oxidants Induces Later in Life a Metabolic Response Associated to a Phenotype of Energy Deficiency in an Animal Model of Total Parenteral Nutrition. Pediatric Research. 68(3). 188–192. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominic Sanfilippo Breakdown of academic impact, for papers by Mostafa Sadeghi Breakdown of academic impact, for papers by S. Roger Breakdown of academic impact, for papers by C. Orlikowski Breakdown of academic impact, for papers by Chris D. Glover Breakdown of academic impact, for papers by Mahzad Alimian Breakdown of academic impact, for papers by N. Nathan Breakdown of academic impact, for papers by Aikaterini Tzortzopoulou Breakdown of academic impact, for papers by Ivan Florentino‐Pineda Breakdown of academic impact, for papers by Malik Benlabed
Rankless by CCL
2026